Stem Cell Umbilical Cord Blood Market Projected to Offer Substantial Growth Opportunities, Reaching $15.2 Billion by 2029

 Grab 20% Off With Code ONLINE20 On Global market Reports — Evaluate Global Trends, Market Risks, and Competitive Intelligence

 



 What Is the Comparative Market Size of the Stem Cell Umbilical Cord Blood Market Between 2025 and 2029?
 The stem cell umbilical cord blood market size has grown rapidly in recent years. It will grow from $6.77 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increasing research and development, increasing demand for private banking services, increasing number of clinical trials, increasing incidence of cancers, and growth in number of fertility clinics.
 
 The stem cell umbilical cord blood market size is expected to see rapid growth in the next few years. It will grow to $15.21 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increasing childbirth rates, increasing demand for stem cell therapies, increasing favorable government policies and initiatives, and increasing focus on regenerative medicine. Major trends in the forecast period include advancements in therapeutic applications, advanced healthcare infrastructure, advancements in cryopreservation techniques, and integration with gene therapy.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp
 
 What Are the Underlying Growth Drivers for the Stem Cell Umbilical Cord Blood Market?
 The increasing childbirth rates are expected to propel the growth of the stem cell umbilical cord blood market going forward. Childbirth rates refer to the number of live births per 1,000 people in a given population over a specific period, usually one year. The increasing childbirth rates are due to the greater availability and affordability of fertility treatments, enabling more families to have children. Umbilical cord blood stem cells are valuable for newborns as they contain hematopoietic stem cells that can be used to treat various blood, immune, and genetic disorders. These cells are a perfect genetic match for the baby and may help siblings or family members. For instance, in April 2025, according to the U.S. Centers for Disease Control and Prevention, a U.S.-based federal agency, the number of births in the USA increased from 3,596,017 in 2023 to 3,622,673 in 2024, reflecting a 1% growth. Therefore, the increasing childbirth rates are driving the growth of the stem cell umbilical cord blood market.
 
 What Are the Major Segments Defining the Structure of the Stem Cell Umbilical Cord Blood Market?
 The stem cell umbilical cord blood market covered in this report is segmented — 
 
 1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
 2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation 
 3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
 4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
 5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
 
 Subsegments:
 1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
 2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells
 
 Which Future-Ready Trends Are Expected to Influence the Stem Cell Umbilical Cord Blood Market?
 Major companies operating in the stem cell umbilical cord blood market are focusing on developing innovative therapies and getting approvals, such cord blood cell therapy to treat rare genetic disorders, improve immune system recovery, and support regenerative medicine applications. Cord blood cell therapy refers to the use of stem cells derived from umbilical cord blood to treat various diseases by regenerating or repairing damaged blood, immune, and other tissue systems. For instance, in October 2024, StemCyte, a US-based biotechnology company, received the regenerative medicine advanced therapy designation from the U.S. Food and Drug Administration (FDA) for hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) for the treatment of Long COVID-19 syndrome. This therapy is cord blood cell therapy that utilizes stem cells from umbilical cord blood to promote healing and reduce inflammation. It has shown potential in treating immune-related and degenerative conditions, offering a non-invasive, ethically sourced option for advanced regenerative treatments.
 
 Which Firms Represent the Competitive Benchmark Within the Stem Cell Umbilical Cord Blood Market?
 Major companies operating in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry. 
 
 Get the detailed stem cell umbilical cord blood market report today
 https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report
 
 Which Regions Are Driving the Highest Demand in the Stem Cell Umbilical Cord Blood Market?
 North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more